$ 84.12
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The...
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITDA, reasonably priced
Target Price
The average target price of MRK is 102 and suggests 21% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
